课题基金 / 基金详情

DEVELOPMENT OF ANTIVIRALS FOR SPECIFIC RNA VIRAL FAMILIES OF PANDEMIC POTENTIAL

DEVELOPMENT OF ANTIVIRALS FOR SPECIFIC RNA VIRAL FAMILIES OF PANDEMIC POTENTIAL
针对具有大流行潜力的特定 RNA 病毒家族开发抗病毒药物
批准号:
10933177
负责人:
GREG HENKEL
金额:
$369.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-22 至 2025-12-31

项目摘要

项目成果

GREG HENKEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To support the advanced development of a promising candidate therapeutic for a virus with pandemic potential included under the Antiviral Program for Pandemics. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FUNCTION OF THE TRANSCRIPTION FACTOR PU1
FUNCTION OF THE TRANSCRIPTION FACTOR PU1
FUNCTION OF THE TRANSCRIPTION FACTOR PU1
国内基金
海外基金
SCIENCE CHINA Chemistry
Science China Chemistry
运用Linkage Chemistry合成新型聚合物缀合物和刷形共聚物
  • 批准号:
    20974058
  • 项目类别:
    面上项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2009
  • 负责人:
    袁金颖
  • 依托单位: